Equities

Encompass Health Corp

Encompass Health Corp

Actions
  • Price (MXN)897.25
  • Today's Change-0.001 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 29 2021 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments692255
Total Receivables, Net612537680
Total Inventory------
Prepaid expenses126127121
Other current assets, total353265
Total current assets842717921
Property, plant & equipment, net3,5103,1522,844
Goodwill, net1,2811,2632,428
Intangibles, net278282418
Long term investments----4.00
Note receivable - long term------
Other long term assets192222250
Total assets6,1025,6376,865
LIABILITIES
Accounts payable170133138
Accrued expenses274237349
Notes payable/short-term debt000
Current portion long-term debt/capital leases252543
Other current liabilities, total187181220
Total current liabilities656576749
Total long term debt2,6882,7423,244
Total debt2,7132,7673,287
Deferred income tax878387
Minority interest650552488
Other liabilities, total374374386
Total liabilities4,4554,3264,954
SHAREHOLDERS EQUITY
Common stock1.201.101.10
Additional paid-in capital1,7871,7302,290
Retained earnings (accumulated deficit)407116142
Treasury stock - common(547)(537)(521)
Unrealized gain (loss)------
Other equity, total------
Total equity1,6481,3101,911
Total liabilities & shareholders' equity6,1025,6376,865
Total common shares outstanding10010099
Treasury shares - common primary issue151515
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.